Articoli con mandati relativi all'accesso pubblico - Gilles MontalescotUlteriori informazioni
Non disponibili pubblicamente: 37
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes …
SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly, CD Joyner, CB Granger, ...
The Lancet 376 (9748), 1233-1243, 2010
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label …
G Montalescot, U Zeymer, J Silvain, B Boulanger, M Cohen, P Goldstein, ...
The Lancet 378 (9792), 693-703, 2011
Mandati: National Institute of Health and Medical Research, France
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
EJ Topol, MG Bousser, KAA Fox, MA Creager, JP Despres, JD Easton, ...
The Lancet 376 (9740), 517-523, 2010
Mandati: US National Institutes of Health
Late consequences of acute coronary syndromes: global registry of acute coronary events (GRACE) follow-up
SMA Alnasser, W Huang, JM Gore, PG Steg, KA Eagle, FA Anderson Jr, ...
The American journal of medicine 128 (7), 766-775, 2015
Mandati: Heart and Stroke Foundation of Canada
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial
JP Collet, E Van Belle, H Thiele, S Berti, T Lhermusier, T Manigold, ...
European heart journal 43 (29), 2783-2797, 2022
Mandati: German Research Foundation
P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction
J Silvain, RF Storey, G Cayla, JB Esteve, JG Dillinger, H Rousseau, ...
Thrombosis and haemostasis 116 (08), 369-378, 2016
Mandati: National Institute of Health and Medical Research, France
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale …
G Montalescot, JF Lassen, CW Hamm, F Lapostolle, J Silvain, ...
American heart journal 165 (4), 515-522, 2013
Mandati: National Institute of Health and Medical Research, France
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)
JP Collet, K Huber, M Cohen, U Zeymer, P Goldstein, C Pollack Jr, ...
The American journal of cardiology 112 (9), 1367-1372, 2013
Mandati: National Institute of Health and Medical Research, France
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA• CER) trial: study design and rationale
TRA The, CER Executive, S Committees
American Heart Journal 158 (3), 327-334. e4, 2009
Mandati: US National Institutes of Health
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors
O Barthélémy, T Limbourg, JP Collet, F Beygui, J Silvain, ...
International journal of cardiology 163 (3), 266-271, 2013
Mandati: National Institute of Health and Medical Research, France
Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients …
HD White, PE Aylward, R Gallo, C Bode, G Steg, SR Steinhubl, ...
American heart journal 159 (1), 110-116, 2010
Mandati: US National Institutes of Health
Copeptin as a prognostic biomarker in acute myocardial infarction
B Lattuca, V Sy, LS Nguyen, M Bernard, M Zeitouni, P Overtchouk, Y Yan, ...
International journal of cardiology 274, 337-341, 2019
Mandati: National Institute of Health and Medical Research, France
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
D Brieger, JP Collet, J Silvain, A Landivier, O Barthelemy, F Beygui, ...
Catheterization and Cardiovascular Interventions 77 (2), 182-190, 2011
Mandati: National Institute of Health and Medical Research, France
Updates and current recommendations for the management of patients with non–ST-elevation acute coronary syndromes: what it means for clinical practice
G Cayla, J Silvain, JP Collet, G Montalescot
The American Journal of Cardiology 115 (5), 10A-22A, 2015
Mandati: National Institute of Health and Medical Research, France
Bleeding complications in primary percutaneous coronary intervention of ST‐elevation myocardial infarction in a radial center
O Barthelemy, J Silvain, D Brieger, A Mercadier, R Lancar, ...
Catheterization and Cardiovascular Interventions 79 (1), 104-112, 2012
Mandati: National Institute of Health and Medical Research, France
Imbalance between fibrin clot formation and fibrinolysis predicts cardiovascular events in patients with stable coronary artery disease
S Neergaard-Petersen, SB Larsen, EL Grove, SD Kristensen, RA Ajjan, ...
Thrombosis and haemostasis 120 (01), 075-082, 2020
Mandati: Danish Council for Technology and Innovation
Factors associated with infarct-related artery patency before primary percutaneous coronary intervention for ST-Elevation myocardial infarction (from the FAST-MI 2010 Registry)
C Bailleul, E Puymirat, N Aissaoui, F Schiele, G Ducrocq, P Coste, ...
The American journal of cardiology 117 (1), 17-21, 2016
Mandati: National Institute of Health and Medical Research, France
Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome
JP Collet, M Kerneis, JS Hulot, SA O’Connor, J Silvain, N Mansencal, ...
Thrombosis and Haemostasis 115 (02), 382-391, 2016
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance
JS Hulot, JP Collet, G Montalescot
Current cardiology reports 13, 451-458, 2011
Mandati: National Institute of Health and Medical Research, France
FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype–phenotype case control study
J Silvain, A Pena, JB Vignalou, JS Hulot, S Galier, G Cayla, ...
Thrombosis and haemostasis 106 (09), 511-520, 2011
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software